#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Post transplant lymphoproliferative disorder Amyloidosis Infection in an immunocompromised host Osteomyelitis Stevens-Johnson syndrome Familial amyotrophic lateral sclerosis Infantile apnoea Osteopetrosis Pulmonary sarcoidosis Microvillous inclusion disease Stiff person syndrome Ventricular tachycardia Mantle cell lymphoma stage II Deafness bilateral Cerebral amyloid angiopathy More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Diagnostics Carcinoid syndrome – Basic Information Pelizaeus-Merzbacher disease Idiopathic inflammatory myopathy – Basic Information Primary hyperoxaluria – Trials in Disease Lysosomal storage disorder Idiopathic inflammatory myopathy – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Cytokine release syndrome – Life with Disease Breast angiosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pamiparib Benzylpenicillin GSKVX000000070965 Gozetotide Alf-18 Cefazolin Sodium Triamcinolone Acetonide Protease Pegipanermin Immunoglobulin G Avalglucosidase Alfa Sulfamethizole Rocatinlimab Prasinezumab Bi-1910 DROSPIRENONE Ferumoxytol Melphalan Hydrochloride Cetrelimab Tyra-300-B01 Salbutamol Sulfate Ph. Eur. More therapies…

    Learn about Your Condition

    Cachexia Femoral hernia Polycythaemia vera Acquired ATTR amyloidosis HER2 positive gastric cancer Breast cancer in situ Congenital pseudarthrosis Monkeypox Carotid artery occlusion Cushing's syndrome Spinal osteoarthritis VEXAS syndrome Mitral valve incompetence Cardiac failure congestive Influenza More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fabry’s disease

  • Title: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisone
    Poland

  • Study on the Safety and Effects of Pegunigalsidase Alfa for Children and Adolescents with Fabry Disease

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pegunigalsidase Alfa
    Austria France Norway Spain

  • A Study of Migalastat Safety and Effects in Children Aged 2 to 12 Years with Fabry Disease and Suitable Gene Changes

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Fabry’s disease
    Belgium Germany Spain

  • Study comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • AGALSIDASE BETA
    • Migalastat
    • Venglustat
    Austria Czechia Denmark France Germany Greece +5

  • Long-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • Isaralgagene Civaparvovec
    Germany

  • Study on the Long-Term Safety and Effectiveness of Pegunigalsidase Alfa for Adults with Fabry Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • Pegunigalsidase Alfa
    Belgium Czechia Denmark Italy Norway
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!